Miyake, Makito https://orcid.org/0000-0001-9503-7356
Nishimura, Nobutaka
Oda, Yuki
Miyamoto, Tatsuki
Iida, Kota
Tomizawa, Mitsuru
Shimizu, Takuto
Owari, Takuya
Ohnishi, Kenta
Hori, Shunta
Morizawa, Yosuke
Gotoh, Daisuke
Nakai, Yasushi
Torimoto, Kazumasa
Fujii, Tomomi
Tanaka, Nobumichi
Fujimoto, Kiyohide
Funding for this research was provided by:
Japan Society for the Promotion of Science (23K08720)
Article History
Received: 9 March 2024
Accepted: 10 September 2024
First Online: 4 October 2024
Declarations
:
: K Fujimoto received honoraria from Merck Biopharma Co., Ltd., MSD K.K., and Ono pharmaceutical Co., Ltd.; received research funding from MSD K.K. and Ono pharmaceutical Co., Ltd.; served in a consulting or advisory role for Ono pharmaceutical Co., Ltd. The research funding from MSD K.K. and Ono pharmaceutical Co., Ltd. was not used for conducting the present study. M Miyake received honoraria from Merck Biopharma Co., Ltd., MSD K.K., and Ono pharmaceutical Co., Ltd.; served in a consulting or advisory role for Merck Biopharma Co., Ltd. and MSD K.K. Other authors disclose no potential conflicts of interest.